Table 3.
Model 1a | Model 2b | Model 3b | |||||||
---|---|---|---|---|---|---|---|---|---|
Microalbuminuriac | GFR < 60 ml/min/1.73 m2 | Cystatin C ≥ 1.0 mg/l | |||||||
Variable | OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value |
SEVR | 0.35 | 0.17–0.73 | .005 | 0.44 | 0.22–0.89 | .02 | 0.31 | 0.13–0.73 | .007 |
eGDR | 0.52 | 0.30–0.89 | .017 | --- | --- | --- | --- | --- | --- |
Heart Rate | 0.72 | 0.38–1.38 | .32 | 0.42 | 0.20–0.88 | .02 | 0.20 | 0.07–0.57 | .003 |
ACEI/ARB Use | --- | --- | --- | 3.57 | 1.18–10.8 | .02 | 5.65 | 1.21–26.4 | .03 |
Hypertension | --- | --- | --- | --- | --- | --- | 6.35 | 1.88–21.5 | .003 |
Odds Ratios are per standardized unit.
Variables available to Model 1: age, SEVR, systolic BP, diastolic BP, eGDR, WHR, BMI, heart rate, ACEI/ARB use, HDL-cholesterol, non-HDL-cholesterol, smoking history, anti-lipidemic agent use
Variables available to Models 2 & 3: Model 1 variables (except age) + hypertension status (BP>130/80 or medication)
Microalbuminuria vs. Normoalbuminuria
Abbreviations: SEVR, subendocardial viability ratio; eGDR, estimated glucose disposal rate; ACEI/ARB, ACE inhibitor/Angiotensin II receptor blocker; BP, blood pressure; BMI, body mass index; WHR, waist-to-hip ratio